These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15796388)

  • 1. Selective ablation of nociceptive neurons for elimination of hyperalgesia and neurogenic inflammation.
    Tender GC; Walbridge S; Olah Z; Karai L; Iadarola M; Oldfield EH; Lonser RR
    J Neurosurg; 2005 Mar; 102(3):522-5. PubMed ID: 15796388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control.
    Karai L; Brown DC; Mannes AJ; Connelly ST; Brown J; Gandal M; Wellisch OM; Neubert JK; Olah Z; Iadarola MJ
    J Clin Invest; 2004 May; 113(9):1344-52. PubMed ID: 15124026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraganglionar resiniferatoxin prevents orofacial inflammatory and neuropathic hyperalgesia.
    Cruz LS; Kopruszinski CM; Chichorro JG
    Behav Pharmacol; 2014 Apr; 25(2):112-8. PubMed ID: 24557321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor redistribution in the dorsal root ganglia correlates with neuropathic pain inhibition after resiniferatoxin treatment.
    Tender GC; Li YY; Cui JG
    Spine J; 2010 Aug; 10(8):715-20. PubMed ID: 20452292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanilloid receptor 1-positive neurons mediate thermal hyperalgesia and tactile allodynia.
    Tender GC; Li YY; Cui JG
    Spine J; 2008; 8(2):351-8. PubMed ID: 18029293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia.
    Neubert JK; Mannes AJ; Karai LJ; Jenkins AC; Zawatski L; Abu-Asab M; Iadarola MJ
    Mol Pain; 2008 Jan; 4():3. PubMed ID: 18199335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice.
    Rashid MH; Inoue M; Bakoshi S; Ueda H
    J Pharmacol Exp Ther; 2003 Aug; 306(2):709-17. PubMed ID: 12724350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo.
    Varga A; Bölcskei K; Szöke E; Almási R; Czéh G; Szolcsányi J; Pethö G
    Neuroscience; 2006 Jun; 140(2):645-57. PubMed ID: 16564637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bee venom injection significantly reduces nociceptive behavior in the mouse formalin test via capsaicin-insensitive afferents.
    Roh DH; Kim HW; Yoon SY; Kang SY; Kwon YB; Cho KH; Han HJ; Ryu YH; Choi SM; Lee HJ; Beitz AJ; Lee JH
    J Pain; 2006 Jul; 7(7):500-12. PubMed ID: 16814689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion.
    Szoke E; Czéh G; Szolcsányi J; Seress L
    Neuroscience; 2002; 115(3):805-14. PubMed ID: 12435419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resiniferatoxin: an ultrapotent selective modulator of capsaicin-sensitive primary afferent neurons.
    Szolcsanyi J; Szallasi A; Szallasi Z; Joo F; Blumberg PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):923-8. PubMed ID: 2243359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist.
    Amaya F; Shimosato G; Kawasaki Y; Hashimoto S; Tanaka Y; Ji RR; Tanaka M
    Pain; 2006 Sep; 124(1-2):175-83. PubMed ID: 16709443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of capsaicin-sensitive nerves and tachykinins in mast cell tryptase-induced inflammation of murine knees.
    Borbély É; Sándor K; Markovics A; Kemény Á; Pintér E; Szolcsányi J; Quinn JP; McDougall JJ; Helyes Z
    Inflamm Res; 2016 Sep; 65(9):725-36. PubMed ID: 27251170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain.
    Pomonis JD; Harrison JE; Mark L; Bristol DR; Valenzano KJ; Walker K
    J Pharmacol Exp Ther; 2003 Jul; 306(1):387-93. PubMed ID: 12721336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanilloid receptor expression and capsaicin excitation of rat dental primary afferent neurons.
    Chaudhary P; Martenson ME; Baumann TK
    J Dent Res; 2001 Jun; 80(6):1518-23. PubMed ID: 11499505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of nerve growth factor in neuropathic pain inhibition produced by resiniferatoxin treatment in the dorsal root ganglia.
    Tender GC; Li YY; Cui JG
    Neurosurgery; 2013 Jul; 73(1):158-65; discussion 165-6. PubMed ID: 23615109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of IA currents by capsaicin in rat trigeminal ganglion neurons.
    Liu L; Simon SA
    J Neurophysiol; 2003 Mar; 89(3):1387-401. PubMed ID: 12626618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac vanilloid receptor-1 afferent depletion enhances stellate ganglion neuronal activity and efferent sympathetic response to cardiac stress.
    Yoshie K; Rajendran PS; Massoud L; Kwon O; Tadimeti V; Salavatian S; Ardell JL; Shivkumar K; Ajijola OA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H954-H966. PubMed ID: 29351450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y Y1 receptor effects on pulpal nociceptors.
    Gibbs JL; Hargreaves KM
    J Dent Res; 2008 Oct; 87(10):948-52. PubMed ID: 18809749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal ganglia in vivo.
    Neubert JK; Maidment NT; Matsuka Y; Adelson DW; Kruger L; Spigelman I
    Brain Res; 2000 Jul; 871(2):181-91. PubMed ID: 10899285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.